|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Re: Malaria ProphylaxisFrom: Justin Ainsworth (skibum@pinsight.com)Wed Nov 27 09:12:26 1996
The Primary Care Update For Ob/Gyn, V3, #6, Nov/Dec 1996 has an article on travel medicine and the author recommends chemoprophylaxis beginning at least 1-2 weeks prior to travel, to be continued for 4 weeks after leaving the endemic area. Current information from CDC at 404-639-1610 can be obtained regarding the appropriate agent for the area of proposed travel. Chloroquine is safe in pregnancy and lactation, however if chloroquine resistant malaria is present in the area, mefloquine (Lariam) is recommended. Mefloquine is not recommended in pregnancy, consequently travel to chloroquine resistant malarial areas has been listed as contraindicated in pregnancy. Women who must take mefloquine should not conceive for the duration of pregnancy and for two months follwoing its discontinuation. However if travel is unavoidable, CDC recommends that fefloquine be given, as malaria infection may be more severe in pregnancy. Ron Ainsworth <ainsron@mem.po.com> Paradise, CA
At 12:17 AM 11/27/96 -0600, you wrote:
>I have a patient going to East Nigeria for 4 weeks and she will be there
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:19:56 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.